Crossmark

Glycovariant-based lateral flow immunoassay to detect ovarian cancer–associated serum CA125

Crossref DOI link: https://doi.org/10.1038/s42003-020-01191-x

Published Online: 2020-08-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bayoumy, Sherif https://orcid.org/0000-0002-7458-4630
Hyytiä, Heidi https://orcid.org/0000-0002-8530-3654
Leivo, Janne

Talha, Sheikh M. https://orcid.org/0000-0003-1997-9530
Huhtinen, Kaisa https://orcid.org/0000-0001-9685-5246
Poutanen, Matti https://orcid.org/0000-0002-8953-1734
Hynninen, Johanna https://orcid.org/0000-0002-0854-7225
Perheentupa, Antti https://orcid.org/0000-0002-1413-6414
Lamminmäki, Urpo

Gidwani, Kamlesh

Pettersson, Kim https://orcid.org/0000-0002-3749-5591
License Information

Text and Data Mining valid from 2020-08-21

Version of Record valid from 2020-08-21
More Information

Article History

Received: 15 April 2020

Accepted: 24 July 2020

First Online: 21 August 2020

Competing interests

: The authors declare no competing interests.